Cipher Pharmaceuticals Inc (CPHRF)
6.932
+0.32
(+4.87%)
USD |
OTCM |
May 10, 09:59
Cipher Pharmaceuticals Price to Book Value: 2.075 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.979 |
| May 08, 2024 | 1.991 |
| May 07, 2024 | 2.021 |
| May 06, 2024 | 2.039 |
| May 03, 2024 | 1.976 |
| May 02, 2024 | 1.955 |
| May 01, 2024 | 1.871 |
| April 30, 2024 | 1.886 |
| April 29, 2024 | 1.868 |
| April 26, 2024 | 1.865 |
| April 25, 2024 | 1.874 |
| April 24, 2024 | 1.865 |
| April 23, 2024 | 1.946 |
| April 22, 2024 | 1.862 |
| April 19, 2024 | 1.856 |
| April 18, 2024 | 1.902 |
| April 17, 2024 | 1.919 |
| April 16, 2024 | 1.940 |
| April 15, 2024 | 2.033 |
| April 12, 2024 | 2.030 |
| April 11, 2024 | 1.981 |
| April 10, 2024 | 1.828 |
| April 09, 2024 | 1.841 |
| April 08, 2024 | 1.832 |
| April 05, 2024 | 1.832 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.898 |
| April 03, 2024 | 1.942 |
| April 02, 2024 | 1.835 |
| April 01, 2024 | 1.782 |
| March 28, 2024 | 1.964 |
| March 27, 2024 | 2.026 |
| March 26, 2024 | 2.133 |
| March 25, 2024 | 2.065 |
| March 22, 2024 | 2.011 |
| March 21, 2024 | 2.011 |
| March 20, 2024 | 1.934 |
| March 19, 2024 | 1.788 |
| March 18, 2024 | 1.856 |
| March 15, 2024 | 1.777 |
| March 14, 2024 | 1.57 |
| March 13, 2024 | 1.576 |
| March 12, 2024 | 1.576 |
| March 11, 2024 | 1.585 |
| March 08, 2024 | 1.567 |
| March 07, 2024 | 1.615 |
| March 06, 2024 | 1.582 |
| March 05, 2024 | 1.555 |
| March 04, 2024 | 1.576 |
| March 01, 2024 | 1.579 |
| February 29, 2024 | 1.552 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2918
Minimum
Mar 23 2020
2.133
Maximum
Mar 26 2024
1.033
Average
0.9899
Median
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.3967 |
| Aurinia Pharmaceuticals Inc | 1.932 |
| Edesa Biotech Inc | 2.377 |
| Lexaria Bioscience Corp | 7.312 |
| Xenon Pharmaceuticals Inc | 3.364 |
Price to Book Value Related Metrics
| PE Ratio | 8.775 |
| PS Ratio | 8.333 |
| Price to Free Cash Flow | 11.02 |
| Price | 6.932 |
| Earnings Yield | 11.40% |
| Market Cap | 167.12M |
| Operating PE Ratio | 17.58 |
| Normalized PE Ratio | 9.066 |